X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (149) 149
male (148) 148
middle aged (111) 111
aged (107) 107
urology & nephrology (105) 105
prostate cancer (103) 103
index medicus (77) 77
adult (68) 68
prostatic neoplasms - pathology (59) 59
prostate-specific antigen - blood (55) 55
cancer (53) 53
urology (49) 49
oncology (42) 42
prostatic neoplasms - diagnosis (41) 41
biopsy (40) 40
diagnosis (39) 39
prostate (38) 38
aged, 80 and over (34) 34
men (32) 32
retrospective studies (32) 32
prostate - pathology (31) 31
prostatic neoplasms - blood (31) 31
medicine & public health (29) 29
sensitivity and specificity (25) 25
antigen (24) 24
prostatic neoplasms - surgery (23) 23
prostatic neoplasms - diagnostic imaging (22) 22
mortality (21) 21
antigens (20) 20
care and treatment (20) 20
analysis (19) 19
prospective studies (18) 18
prostatectomy (18) 18
prostatic neoplasms (18) 18
radical prostatectomy (18) 18
risk factors (18) 18
prostate-specific antigen (17) 17
research (17) 17
tumors (17) 17
disease (16) 16
female (16) 16
metastasis (16) 16
neoplasm staging (16) 16
risk (16) 16
ultrasonography (16) 16
ultrasound (16) 16
carcinoma (15) 15
endocrinology & metabolism (15) 15
prostatectomy - methods (15) 15
prostatic neoplasms - epidemiology (15) 15
treatment outcome (15) 15
cohort studies (14) 14
austria - epidemiology (13) 13
bladder cancer (13) 13
follow-up studies (13) 13
health aspects (13) 13
impact (13) 13
predictive value of tests (12) 12
prognosis (12) 12
roc curve (12) 12
surgery (12) 12
contrast media (11) 11
nephrology (11) 11
oncology, experimental (11) 11
prostate - diagnostic imaging (11) 11
psa (11) 11
urology/andrology (11) 11
biopsy, needle (10) 10
experience (10) 10
serum (10) 10
austria (9) 9
biomarkers, tumor - blood (9) 9
medical colleges (9) 9
screening (9) 9
sonography (9) 9
ultrasonography, doppler, color (9) 9
young adult (9) 9
biopsy, needle - methods (8) 8
cancer detection (8) 8
diagnosis, differential (8) 8
expression (8) 8
imaging / radiology (8) 8
incidence (8) 8
mass screening (8) 8
population (8) 8
prostata (8) 8
prostatic neoplasms - metabolism (8) 8
prostatic neoplasms - mortality (8) 8
recurrence (8) 8
survival (8) 8
therapy (8) 8
adenocarcinoma (7) 7
adolescent (7) 7
age (7) 7
biopsy - methods (7) 7
chemotherapy (7) 7
cystectomy (7) 7
cytology (7) 7
density (7) 7
development and progression (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


memo - Magazine of European Medical Oncology, ISSN 1865-5041, 12/2018, Volume 11, Issue 4, pp. 305 - 308
Oligometastatic prostate cancer has been considered an intermediate state between localized disease and widespread metastases, but there is no consensus on the... 
Oligometastatic prostate cancer | Local therapy | Medicine & Public Health | Radical prostatectomy | Oncology | Metastasis-directed therapy | Medicine/Public Health, general | Medical colleges | Metastasis | Prostate cancer | Analysis | Surgery
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2009, Volume 106, Issue 44, pp. 18437 - 18442
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 7/2015, Volume 42, Issue 8, pp. 1284 - 1294
To assess the association between PSA levels, PSA kinetics and other factors and a pathological 68Ga-PSMA PET/CT scan in patients with recurrent prostate... 
68 Ga-PSMA PET/CT | Biochemical relapse | Salvage radiotherapy | Medicine & Public Health | Orthopedics | PSA doubling time | Oncology | Nuclear Medicine | Imaging / Radiology | Cardiology | Recurrent prostate cancer | Ga-PSMA PET/CT
Journal Article
BJU International, ISSN 1464-4096, 01/2018, Volume 121, Issue 1, pp. 29 - 37
Objectives To evaluate the diagnostic accuracy of the Xpert Bladder Cancer (BC) Monitor, compared with cystoscopy and cytology in the oncological follow‐up of... 
recurrence | blcsm | follow‐up | mRNA‐based markers | urine markers | surveillance | BladderCancer | follow-up | mRNA-based markers | UROLOGY & NEPHROLOGY | Medical tests | Messenger RNA | Diagnosis | Bladder cancer | Mandatory drug testing | Urine | Accuracy | Cellular biology | Surveillance | Urinary bladder | Invasiveness | Cytology | mRNA | Insulin-like growth factor II | Tumors | Cancer
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 10/2018, Volume 45, Issue 11, pp. 1873 - 1883
Journal Article
Urology case reports, ISSN 2214-4420, 05/2019, Volume 24, p. 100882
Prolonged low-flow priapism causes structural impotence. We describe a case where potency has been preserved by off-centre corporal dilation to spare the... 
Journal Article